Key facts
| Price (PPV) | 20.40 MAD |
|---|---|
| Dispensing status | Schedule A — prescription only |
| Composition (DCI) | néomycinepolymixinedexaméthasone |
| Class | Otologicals |
| ATC code | S02CA06 |
| Manufacturer | PROMOPHARM (HIKMA) |
| Presentation | Flacon de 10 ml |
| Hospital price | 12.70 MAD |
| Data collected on | 9/8/2026 |
Indications
Traitement local des otites externes d’origine bactérienne à tympan fermé, en particulier eczéma infecté du conduit auditif externe. Ce médicament ne doit jamais être utilisé en cas de perforation tympanique en raison du risque d’ototoxicité. Il convient de tenir compte des recommandations officielles concernant l’utilisation appropriée des antibactériens.
Find an open pharmacy
On-call pharmacies near you
About Polydexa
Polydexa belongs to the otologicals therapeutic class. In Morocco, this drug is marketed by PROMOPHARM (HIKMA) and is among the pharmaceutical specialties referenced by the Ministry of Health.
For any question about the use, effects, or drug interactions of Polydexa, consult your doctor or pharmacist. This information is provided for educational purposes and does not replace medical advice.
Frequently Asked Questions about Polydexa
Answers to common questions from Moroccan patients about this drug.